Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
WATCH: What we have learned so far and other thoughts on the new European patent litigation system
Americas
WATCH: What we have learned so far and other thoughts on the new European patent litigation system
The Unified Patent Court (UPC) opened for business in June 2023. In this session, Ravi Srinivasan, partner at JA Kemp, explains how UPC litigation has been shaping up over the past year and shares practical tips based on experiences so far.   24 December 2024
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Americas
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment.   24 December 2024
WATCH: The Unified Patent Court from the Frontline
Americas
WATCH: The Unified Patent Court from the Frontline
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid.   24 December 2024
Americas
WATCH: Jurisdictional overreach of foreign courts in patent disputes
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration.   22 December 2024
Americas
WATCH: Revolutionising healthcare – medtech’s impact on patent strategy
Speakers from Auctus Surgical, RefleXion Medical and Bird & Bird discuss how innovation in medtech is reshaping patent strategies across the life sciences sector.   20 December 2024
Americas
WATCH: Bridging academia and industry - how can universities and industry work most effectively together?
Speakers from Mammoth Biosciences, Cargo Therapeutics, Star Therapeutics, and Greenberg Traurig, discuss academia and industry, technology transfer, and leveraging research for commercialisation.   19 December 2024
Americas
WATCH: AI and machine learning in drug discovery - patenting AI-generated inventions
Speakers from Akin, Bristol Myers Squibb, Gilead Sciences, and Pfizer discuss how AI accelerates drug discovery, from target identification to predictive modelling, reducing costs and enhancing therapeutic outcomes.   19 December 2024
Americas
WATCH: Intersectionality of IP with licensing and commercialisation
Speakers from Philips Ormonde Fitzpatrick, Axinn Veltrop & Harkrider, and Leason Ellis discuss how IP rights are not merely legal tools but strategic assets that can significantly influence a product’s lifecycle, from development to market.   19 December 2024
Americas
Novartis shields eye-drop patent at European Patent Office
Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company’s application.   19 December 2024
Americas
WATCH: What are the latest challenges in patenting biologics, biosimilars, and bispecific antibodies?
Speakers from HTD Biosystems, Nutcracker Therapeutics, and Haynes & Boone examine the evolving patent landscape for biologics, biosimilars, and bispecific antibodies, sharing practical strategies and jurisdiction-specific insights.   18 December 2024